These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 3839562

  • 1. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ, Jenden DJ.
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [Abstract] [Full Text] [Related]

  • 2. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
    Thomas EA, Hsu HH, Griffin MT, Hunter AL, Luong T, Ehlert FJ.
    Mol Pharmacol; 1992 Apr; 41(4):718-26. PubMed ID: 1569923
    [Abstract] [Full Text] [Related]

  • 3. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 4. Effects of an alkylating derivative of oxotremorine (BM 123A) on heart rate, muscarinic receptors and adenylate cyclase activity in the rabbit myocardium.
    Ehlert FJ.
    J Pharmacol Exp Ther; 1987 Jun; 241(3):804-11. PubMed ID: 3598904
    [Abstract] [Full Text] [Related]

  • 5. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M, Waelbroeck M, Christophe J.
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [Abstract] [Full Text] [Related]

  • 6. The conversion of 2-chloroalkylamine analogues of oxotremorine to aziridinium ions and their interactions with muscarinic receptors in the guinea pig ileum.
    Ringdahl B, Resul B, Ehlert FJ, Jenden DJ, Dahlbom R.
    Mol Pharmacol; 1984 Sep; 26(2):170-9. PubMed ID: 6332977
    [Abstract] [Full Text] [Related]

  • 7. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [Abstract] [Full Text] [Related]

  • 8. An alkylating derivative of oxotremorine interacts irreversibly with the muscarinic receptor.
    Ehlert FJ, Jenden DJ, Ringdahl B.
    Life Sci; 1984 Mar 05; 34(10):985-91. PubMed ID: 6700365
    [Abstract] [Full Text] [Related]

  • 9. Muscarinic actions and receptor binding of the enantiomers of BM 130, an alkylating analog of oxotremorine.
    Ringdahl B, Katz ED, Roch M, Jenden DJ.
    J Pharmacol Exp Ther; 1989 Apr 05; 249(1):210-5. PubMed ID: 2709331
    [Abstract] [Full Text] [Related]

  • 10. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1985 Jun 05; 233(3):707-14. PubMed ID: 3839264
    [Abstract] [Full Text] [Related]

  • 11. Evidence of paired M2 muscarinic receptors.
    Potter LT, Ballesteros LA, Bichajian LH, Ferrendelli CA, Fisher A, Hanchett HE, Zhang R.
    Mol Pharmacol; 1991 Feb 05; 39(2):211-21. PubMed ID: 1899905
    [Abstract] [Full Text] [Related]

  • 12. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR, Wolfe BB.
    Mol Pharmacol; 1984 Sep 05; 26(2):164-9. PubMed ID: 6548291
    [Abstract] [Full Text] [Related]

  • 13. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
    Baker SP, Posner P.
    Mol Pharmacol; 1986 Nov 05; 30(5):411-8. PubMed ID: 3773882
    [Abstract] [Full Text] [Related]

  • 14. Coupling of muscarinic receptors to adenylate cyclase in the rabbit myocardium: effects of receptor inactivation.
    Ehlert FJ.
    J Pharmacol Exp Ther; 1987 Jan 05; 240(1):23-30. PubMed ID: 3806386
    [Abstract] [Full Text] [Related]

  • 15. Analysis of cardiac muscarinic receptors recognized selectively by nonquaternary but not by quaternary ligands.
    Brown JH, Goldstein D.
    J Pharmacol Exp Ther; 1986 Aug 05; 238(2):580-6. PubMed ID: 3016242
    [Abstract] [Full Text] [Related]

  • 16. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.
    Ehlert FJ.
    J Pharmacol Exp Ther; 1988 Nov 05; 247(2):596-602. PubMed ID: 3183955
    [Abstract] [Full Text] [Related]

  • 17. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S, Musílková J, Nedoma J, Proska J, Shelkovnikov S, Vorlícek J.
    Mol Pharmacol; 1990 Nov 05; 38(5):674-80. PubMed ID: 2233700
    [Abstract] [Full Text] [Related]

  • 18. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ, Tran LP.
    J Pharmacol Exp Ther; 1990 Dec 05; 255(3):1148-57. PubMed ID: 2262898
    [Abstract] [Full Text] [Related]

  • 19. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C, el-Fakahany EE.
    Mol Pharmacol; 1990 Jun 05; 37(6):893-902. PubMed ID: 2163015
    [Abstract] [Full Text] [Related]

  • 20. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR, Wolfe BB.
    J Pharmacol Exp Ther; 1985 Jul 05; 234(1):37-44. PubMed ID: 3839265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.